EPL Limited announced robust financial results for the first quarter of FY27, reporting a 25.3% increase in revenue to INR XXX crore. The company also saw a 15.2% rise in EBITDA and maintained healthy margins. Driven by this performance, EPL has raised its full-year revenue growth guidance to high teens and reaffirmed its EBITDA margin expectations.
EPL Limited Reports Strong Q1 FY27 Performance
EPL Limited has posted impressive financial results for the first quarter ending June 30, 2026 (Q1 FY27), demonstrating significant growth amidst a volatile environment. The company reported a revenue growth of 25.3%, reaching a new high. This performance is attributed to broad-based growth across its product categories and geographies, with Beauty & Cosmetics and Oral Care segments both exceeding 20% growth.
Key Financial Highlights
EBITDA saw a healthy increase of 15.2%, reaching INR XXX crore. The company successfully managed cost inflation through judicious pricing strategies, maintaining an underlying EBITDA margin of 19.6%. This marks the fifth consecutive quarter of double-digit revenue growth and the 15th consecutive quarter of double-digit EBITDA growth. Return on capital employed stood at a strong 18.5%.
Strategic Initiatives and Outlook
EPL highlighted its continued focus on innovation, sustainability, and operational excellence. The company is progressing with its proposed merger with Indovida, which is expected to provide a significant step into rigid plastic packaging and expand its reach into emerging markets. Looking ahead, EPL has raised its full-year revenue growth guidance to high teens while maintaining its underlying EBITDA margin guidance of 20%. The company expressed confidence in its ability to deliver sustainable, profitable growth and create enduring value.
Geographical and Segment Performance
Regionally, EAP led the growth with 34.3%, followed by the Americas at 29.4%, and Europe and AMESA at 20.2% and 17% respectively. The Beauty & Cosmetics segment grew by over 20%, and Oral Care also surpassed the 20% growth mark. Personal Care & Beyond now constitutes 54% of the portfolio.
Source: BSE
